Plastic pre-fillable syringes and vials: Progress towards a wider acceptance

American Pharmaceutical Review

Volumn 13, Issue 2, 2010, Pages 12-16

  Eakins, Michael N ^a  

^a Eakins and Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKENE; PLASTIC; POLYPROPYLENE; SILICONE; TUNGSTEN;

CONTAINER; DRUG INDUSTRY; DRUG PACKAGING; DRUG STORAGE; DRUG TRANSPORT; FREEZE DRYING; PACKAGING MATERIAL; PHYSICAL CHEMISTRY; POLYMERIZATION; REVIEW; SAFETY; SYRINGE; VIAL;

EID: 77951565249     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Romacker M, Schoenknecht T, Forster T. The Rise of Prefilled Syringes from Niche Product to Primary Container of Choice: A Short History. OnDrugDelivery 4-5, April 2008.
2. Eakins MN. New Plastics for Old Vials. BioProcess International 3: 52-58, 2005.
3. Blackburn J, Hawley RT. Contrast Packaging: Implications for Cost and Employee Safety. October 16, 2006. www.AuntMinnie.com. Accessed December 9. 2009.
4. Shin JY et al. Chemical Structure and Physical Properties of Cyclic Olefin Copolymers. Pure Appl. Chem. 77(5): 801-814, 2005.
5. Lamonte RR, McNally D. Uses and Processing of Cyclic Olefin Copolymers (COC). Plastic Engineering 56: 51-59, 2000. (Pubitemid 35338085)
6. Khanarian G. Optical Properties of Cyclic Olefin Copolymers. Opt. Eng. 40 (6): 1024-1029, 2001.
7. Qadry SS et al. Model Development for O2 and N2 Permeation Rates Through CZ-Resin Vials. Int. J. Pharmaceutics 188: 173-179, 1999.
8. Eakins MN. The Design and Construction of Pre-filled Syringes. Am. Pharm. Rev. 10: 47-51, 2007.
9. Baxter Posts Strong Sales and Earnings for Third Quarter 2008: Consolidated Statement of Income Three Months Ending September 30, 2008. Baxter International Inc. Corporate News Release October 16, 2008.
10. Verjans B, Thilly J, Vandecasserie C. A New Concept in Aseptic Filling: Closed-Vial Technology. Pharm. Technol. Aseptic Processing Supplement, S24-S29, 2005.
11. Thilly J, Conrad D, Vandecasserie C. Aseptic Filling of Closed, Ready-to-Fill Containers. Pharm. Eng. 26 (2): 66-74, 2006.
12. Facility of the Year Award Winner Equipment Innovation Aseptic Technologies. Pharm. Processing, page 22, March 2009.
13. Thilly J, Mayeresse Y. Freeze-drying with Closed Vials. Pharm. Technol. November 1, 2008.
14. Buoma M et al. Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Investigational Polymer-Conjugated Platinum Anticancer Agent AP 5280. Drug Development and Industrial Pharmacy 29 (9): 981-995, 2003.
15. Stout D, Vilivalam V. Plastic Prefilled Syringes. A Better Fit for Autoinjector Systems. Pharmaceutical Technology Injectables S6-S8, 2009.
16. Qadry SS et al. Evaluation of CZ-Resin Vials for Packaging Protein-Based Parenteral Formulations. Int. J. Pharmaceutics 252: 207-212, 2003.
17. Lee H et al. Tungsten Leaching from Pre-filled Syringes and Impact on Protein Aggregation. Presented at PDA 2007 Extractables and Leachables Forum, Bethesda, November, 2007.
18. Jones LS, Kaufmann A, Middaugh CR. Silicone Oil Induced Aggregation of Proteins. J. Pharm. Sci. 94: (4) 918-927, (2004).
19. Lahendro B. The Next Generation of Ready-to-Use Prefillable Syringes: First in Silicone-free Solutions. Pre-filled Syringes; the Container of Choice for Today's Injectables. OnDrugDelivery 24-26, April 2008.
20. Vilivalam VD. Daikyo Crystal Zenith Packaging Systems for Biopharmaceutical Drug Delivery. Presented at PharmaEd Resources Pre-filled Syringes Forum, Philadelphia, March 2009.
21. Committee for Proprietary Medicinal Products Guideline on Plastic Primary Packaging Materials CPMP/QWP/4359/03-Consultation, February 25, 2004. www.emea.int/pdfs/human/qwp/435903en.pdf
22. US Food and Drug Administration Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics - Chemistry, Manufacturing, and Controls Documentation, May 1999. www.fda.gov/cder/guidance/1714fnl.pdf
23. General Chapter 〈87〉 Biological Reactivity Tests, In Vitro. United States Pharmacopeia32 - National Formulary 27, 2009.
24. General Chapter 〈88〉 Biological Reactivity Tests, In Vivo. United States Pharmacopeia 32 - National Formulary 27, 2009.
25. General Chapter 〈661〉 Containers - Plastics. United States Pharmacopeia 32 - National Formulary 27, 2009.
26. General Chapter 〈671〉 Containers - Performance Testing. United States Pharmacopeia 32 - National Formulary 27, 2009.
27. General Chapter 〈660〉 Containers - Glass. United States Pharmacopeia 32 - National Formulary 27, 2009.
28. Chapter 3.1. Materials Used for the Manufacture of Containers. European Pharmacopoeia 6.0, 2008.
29. Chapter 3.1.3. Polyolefins. European Pharmacopoeia 6.0, 2008.
30. Chapter 3.2.2. Plastic Containers and Closures for Pharmaceutical Use. European Pharmacopoeia 6.0, 2008.
31. Chapter 3.2.2.1. Plastic Containers for Aqueous Solutions for Parenteral Infusion. European Pharmacopoeia 6.0, 2008.
32. US Food and Drug Administration Guideline for Drug Master Files September 1989. www.fda.gov/cder/guidance/dmf.htm